Literature DB >> 21722979

Improved cardiac survival, freedom from MACE and angina-related quality of life after successful percutaneous recanalization of coronary artery chronic total occlusions.

Francesco Borgia1, Nicola Viceconte, Omar Ali, Claire Stuart-Buttle, Anjana Saraswathyamma, Rosario Parisi, Francesca Mirabella, Konstantinos Dimopoulos, Carlo Di Mario.   

Abstract

BACKGROUND: Most percutaneous recanalizations of coronary artery chronic total occlusion (CTO) are not attempted because of the skepticism on their long-term clinical benefit. We assessed the effect of percutaneous CTO recanalization procedures on long-term cardiac survival, freedom from MACE and angina-related quality of life (AQL).
METHODS: All consecutive patients who underwent attempt of percutaneous native coronary artery CTO recanalization between 2003 and 2009 were included in the study. MACE was defined as combined cardiac death, myocardial infarction (MI) and target vessel revascularization (TVR). AQL was assessed by the Seattle Angina Questionnaire-UK-version (SAQ-UK).
RESULTS: Among 302 patients who received an attempt of percutaneous CTO recanalization, 237 (78%) had a successful procedure while in 65 (22%) the procedure failed. Overall intra-hospital complication rate was 3.0%, with no difference between the two groups. Median follow-up was 4.0 years, during which 13 patients had a fatal cardiac event. Patients in whom the CTO recanalization procedure failed had a higher risk of cardiac death (HR 3.39; 95% CI 1.14-10.1;p=0.03; after propensity score adjustment, HR 2.83; 95% CI 0.89-8.96;p=0.07) and MACE (HR 5.40; 95% CI 2.71-10.5;p<0.001; adjusted HR 3.34; 95% CI 1.47-7.58;p=0.003) compared to patients with successful procedure. CTO recanalization significantly improved the AQL during follow-up: patients with successful procedure experienced less physical activity limitation (p=0.01), rarer angina episodes (p<0.001) and greater treatment satisfaction (p=0.03) compared to patients with failed procedure.
CONCLUSIONS: Patients with successful CTO recanalization had a trend towards better cardiac survival and significant lower risk of MACE and improvement of AQL compared to patients with failed procedures.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21722979     DOI: 10.1016/j.ijcard.2011.04.023

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  18 in total

Review 1.  Approach to CTO Intervention: Overview of Techniques.

Authors:  Aris Karatasakis; Barbara Anna Danek; Dimitri Karmpaliotis; Khaldoon Alaswad; Minh Vo; Mauro Carlino; Mitul P Patel; Stéphane Rinfret; Emmanouil S Brilakis
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-01

2.  Impact of multi-vessel versus single-vessel disease on outcomes after percutaneous coronary interventions for chronic total occlusions.

Authors:  Aurel Toma; Barbara E Stähli; Michael Gick; Cathérine Gebhard; Thomas Nührenberg; Kambis Mashayekhi; Miroslaw Ferenc; Franz-Josef Neumann; Heinz Joachim Buettner
Journal:  Clin Res Cardiol       Date:  2017-02-24       Impact factor: 5.460

Review 3.  Contemporary overview and clinical perspectives of chronic total occlusions.

Authors:  Loes P Hoebers; Bimmer E Claessen; George D Dangas; Truls Råmunddal; Roxana Mehran; José P S Henriques
Journal:  Nat Rev Cardiol       Date:  2014-05-27       Impact factor: 32.419

4.  Health Status Benefits of Successful Chronic Total Occlusion Revascularization Across the Spectrum of Left Ventricular Function: Insights From the OPEN-CTO Registry.

Authors:  Yevgeniy Khariton; Sophia Airhart; Adam C Salisbury; John A Spertus; Kensey L Gosch; J Aaron Grantham; Dimitrios Karmpaliotis; Jeffrey W Moses; William J Nicholson; David J Cohen; William Lombardi; James Sapontis; James M McCabe
Journal:  JACC Cardiovasc Interv       Date:  2018-11-26       Impact factor: 11.195

5.  Quality of life benefits of percutaneous coronary intervention for chronic occlusions.

Authors:  David M Safley; J Aaron Grantham; Jason Hatch; Philip G Jones; John A Spertus
Journal:  Catheter Cardiovasc Interv       Date:  2013-12-19       Impact factor: 2.692

6.  Contrast-induced nephropathy following chronic total occlusion percutaneous coronary intervention in patients with chronic kidney disease.

Authors:  Yuan-Hui Liu; Yong Liu; Ning Tan; Ji-Yan Chen; Ying-Ling Zhou; Jian-Fang Luo; Dan-Qing Yu; Li-Wen Li; Hua-Long Li; Piao Ye; Peng Ran
Journal:  Eur Radiol       Date:  2015-05-17       Impact factor: 5.315

Review 7.  Treatment of refractory angina in patients not suitable for revascularization.

Authors:  Timothy D Henry; Daniel Satran; E Marc Jolicoeur
Journal:  Nat Rev Cardiol       Date:  2013-12-24       Impact factor: 32.419

8.  New Advances in Chronic Total Occlusions.

Authors:  Nikolaos Konstantinidis; Michele Pighi; Ismail Dogu Kilic; Roberta Serdoz; Georgios Sianos; Carlo Di Mario
Journal:  Interv Cardiol       Date:  2014-08

9.  Survival after percutaneous coronary intervention for chronic total occlusion.

Authors:  Aurel Toma; Michael Gick; Jan Minners; Miroslaw Ferenc; Christian Valina; Nikolaus Löffelhardt; Catherine Gebhard; Florian Riede; Franz-Josef Neumann; Heinz Joachim Buettner
Journal:  Clin Res Cardiol       Date:  2016-06-01       Impact factor: 5.460

10.  Prevalence and management of coronary chronic total occlusions in a tertiary Veterans Affairs hospital.

Authors:  Omar M Jeroudi; Mohammed E Alomar; Tesfaldet T Michael; Abdallah El Sabbagh; Vishal G Patel; Owen Mogabgab; Eric Fuh; Daniel Sherbet; Nathan Lo; Michele Roesle; Bavana V Rangan; Shuaib M Abdullah; Jeffrey L Hastings; Jerrold Grodin; Subhash Banerjee; Emmanouil S Brilakis
Journal:  Catheter Cardiovasc Interv       Date:  2013-11-13       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.